Scheeler Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Scheeler Financial’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$408K	Buy	+217,452	New	+$485K	0.31%	41

Other funds holding LXRX

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Straight Path Wealth Management Jenison, Michigan $449M AUM 10.17% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return

Invera Wealth Advisors Bend, Oregon $194M AUM 26.64% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Scheeler Financial's LXRX Position: Q3 2026 in Review

Scheeler Financial opened a new position in Lexicon Pharmaceuticals (LXRX) in Q3 2026: 217,452 shares worth $408K. The stake represents 0.31% of the portfolio and ranks #41 among its holdings.

24 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

Scheeler Financial held 217,452 shares of Lexicon Pharmaceuticals worth $408K as of Q3 2026.
Lexicon Pharmaceuticals was a new Scheeler Financial position in Q3 2026.
Lexicon Pharmaceuticals made up 0.31% of Scheeler Financial's portfolio in Q3 2026, its #41 holding.
24 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on Scheeler Financial's 13F filing for Q3 2026, filed 13 Oct 2026.